OQROGet OQRO Pro
Insider trade

Becton Dickinson (BDX)Officer sold ~$14K

Michael Feld, Officer at Becton Dickinson, sold ~$14K of Becton Dickinson shares.

~$14K
Approx. value · 76 sh @ $183.70
20K
Holds after · shares reported
Traded
Sep 28, 2026
Filed
Sep 30, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 30, 2026FDARecall: BD Needle Kit for Powered Driver 15mm x 15Ga, REF: D015151NK, BD Needle Kit for Powered Driver 25mm x 15Ga, REF: D015251NK, BD Needle Kit for Powered Driver 35…
  2. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
  3. Aug 6, 20265% stakeFirst Eagle Investment Management, LLC reported a passive stake (13G) of 5.1%
  4. Aug 7, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.4%
  5. Aug 10, 2026FDARecall: Power-Trialysis Short-Term Straight Dialysis Catheter, REF: 5605150; Power-Trialysis Short-Term Straight Dialysis Catheter, REF: 5605200; Power-Trialysis Short…
  6. Aug 10, 2026FDARecall: DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625150; DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625200; DuoGlide Short-Term Straight Dialys…
  7. Aug 11, 2026FDARecall: ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI code: 00690103210927 The non-invasive ForeSight oximeter cable is intended for use as an adjunct moni…
  8. Aug 11, 2026InsiderOfficer sold ~$441K of BDX shares in the open market
  9. Aug 13, 2026InsiderCEO sold ~$768K of BDX shares in the open market
  10. Aug 14, 2026FDAFDA device clearance: EnCor EnCompass™ Breast Biopsy and Tissue Removal System
  11. Aug 26, 2026InsiderOfficer sold ~$31K of BDX shares in the open market
  12. Sep 14, 2026FDAFDA device clearance: BD BBL Mueller Hinton II Broth (Cation-Adjusted); BD Difco Mueller Hinton Broth
  13. Sep 25, 2026FDAFDA device approval: Liverty™ TIPS Stent Graft
  14. Sep 28, 2026 · this disclosureInsiderOfficer sold ~$14K of BDX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 28 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

Other recent filings by Michael Feld, EVP, Chief Revenue Officer

The full history of Michael Feld, EVP, Chief Revenue Officer is on the profile page.

How this filing works

Other disclosures at Becton Dickinson

Everything OQRO holds on this company is on its BDX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data